Non-alcoholic steatohepatitis and hepatic fibrosis are strongly associated with estimated 10-years cardiovascular risk in people living with severe obesity

14 April 2023 (16:35 - 17:20)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Fannie Lajeunesse-Trempe

Quebec Heart and Lung Institute, Quebec (Canada)

5 More presentations in this session

Presentation thumbnail

Role of risk assessment using lipid ratios and adiposity markers in young patients with a first acute coronary syndrome

Doctor L. Fernandez Ruz (Malaga, ES)

Abstract Slides

Presentation thumbnail

Potential for optimizing management of overweight and obesity in patients with established atherosclerotic coronary artery disease

Assistant Professor I. Burazor (Belgrade, RS)

Abstract Slides

Presentation thumbnail

Associations of short-term changes in obesity indices with cardiovascular disease and all-cause mortality among overweight and obese adults

Miss L. Wang (Hong Kong, CN)

Abstract Slides

Presentation thumbnail

The explanation of educational disparities in adiposity by lifestyle, socioeconomic and mental health mediators

Mrs A. Bartoskova Polcrova (Brno, CZ)

Abstract Slides

Presentation thumbnail

Cardiac rehabilitation designed for obese patients with atrial fibrillation: OPTICARE XL results on burden, frequency and severity of Atrial Fibrillation

Mrs N. Tenbult - van Limpt (Eindhoven, NL)

Abstract Slides

Access the full session

Session thumbnail

Moderated ePoster 35

The Event

Event poster

ESC Preventive Cardiology 2023

14 April 2023 16:35 CET

You may be interested in

Congress Session

Obesity as a cardiovascular disease: integrated management

Webinar

Obesity management: implications for cardiovascular risk reduction

Congress Session

ESC Clinical Consensus Statement on Obesity and Cardiovascular Disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources